Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$55.63 - $73.24 $615,601 - $810,473
-11,066 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$52.05 - $66.51 $136,006 - $173,790
2,613 Added 30.91%
11,066 $728,000
Q2 2018

Aug 10, 2018

SELL
$48.33 - $55.64 $1.36 Million - $1.56 Million
-28,068 Reduced 76.85%
8,453 $427,000
Q1 2018

May 22, 2018

SELL
$44.44 - $54.39 $59.7 Million - $73 Million
-1,342,438 Reduced 97.35%
36,521 $1.38 Million
Q1 2018

May 21, 2018

BUY
$44.44 - $54.39 $59.8 Million - $73.2 Million
1,346,075 Added 4093.4%
1,378,959 $1.38 Million
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $1.24 Million - $1.57 Million
32,884
32,884 $1.63 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $363M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.